Ashkon Software

   







 


FLDM - Fluidigm Corporation

Fluidigm Corporation logo Fluidigm Corporation (FLDM) is a life sciences company that develops and markets innovative technologies and products for the analysis of biological systems. The company's products and services are used in a range of applications, including genomics research, single-cell analysis, and clinical diagnostics. Fluidigm Corporation is headquartered in South San Francisco, California.

Fluidigm Corporation had a market capitalization of approximately $931 million. The company's total revenue for the fiscal year 2020 was $147.8 million, representing an increase from $144.6 million in the previous year. Net loss for the same period was $51.5 million, a decrease from a net loss of $59.7 million in the previous year.

Fluidigm Corporation's innovative technologies and products have enabled researchers to gain deeper insights into biological systems, and have contributed to advances in genomics research and personalized medicine. The company has a strong intellectual property portfolio, and has formed strategic partnerships with a range of organizations to expand the reach of its products and services.

The life sciences industry is subject to various risks, including regulatory risks and competition from other companies. However, Fluidigm Corporation's strong track record of innovation and strategic partnerships should position it well for continued success in the future.

Fluidigm Corporation's stock is listed on the NASDAQ stock exchange under the ticker symbol FLDM. Investors should carefully consider their investment objectives, risk tolerance, and other factors before investing in Fluidigm Corporation or any other life scienc

 



 

 

 
Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer